Skip to main content

AdaptHealth Corp. (AHCO) Stock Analysis

SellModerate Confidence

Healthcare · Medical Devices

Sell if holding. Engine safety override at $10.66: Quality below floor (1.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10. Specifically: Below-average business quality; Negative price momentum.

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company... Read more

$10.66+14.3% A.UpsideScore 5.1/10#33 of 40 Medical Devices
QualityF-score5 / 9FCF yield18.47%
Stop $10.24Target $12.18(analyst − 13%)A.R:R 1.3:1
Analyst target$14.00+31.3%8 analysts
$12.18our TP
$10.66price
$14.00mean
$18

Sell if holding. Engine safety override at $10.66: Quality below floor (1.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10. Specifically: Below-average business quality; Negative price momentum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.1/10, moderate confidence.

Passes 5/8 gates (no SEC red flags, news events none recent, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and clean insider activity. Suitability: aggressive.

Recent Developments — AdaptHealth Corp.

Generated 2026-05-20T20:21:21Z.

Thesis

Rewards
No bull case signals
Risks
Quality below floor (1.9 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)8.8
Mkt Cap$1.5B
EV/EBITDA5.8
Profit Mgn-2.4%
ROE-4.8%
Rev Growth5.4%
Beta1.57
DividendNone
Rating analysts14

Quality Signals

Piotroski F5/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

5 floor-breakers·1 ceiling hit

Unprofitable operations — net margin -2.4%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Gross Margin
0.1
Operating Margin
0.3
Roa
1.8
Moat
3.6
Current Ratio
3.7
Piotroski F
5.6
No competitive moatQuality concerns

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Obv
1.0
Volume
1.4
Ma Position
4.0
Rsi
8.8
Oversold in uptrend (RSI 18)Volume distribution (falling OBV)Above 200-day MA

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Erm
5.0
Earnings Timing
5.0
News Activity
5.0
Earnings concerns: 0B/4M

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
3.8
Low model confidence on this dimension (33%).

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
2.7
Growth Rank
3.3
Value Rank
9.5
GatesMomentum 3.0<4.5A.R:R 1.3 < 1.5@spotINSIDER 3.37%=EXTREMENo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 79d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
18 · Oversold
20D MA 50D MA 200D MAGOLDEN CROSSSupport $10.56Resistance $13.43

Price Targets

$10
$12
A.Upside+14.3%
A.R:R1.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (1.9 < 4.0)
! Momentum score 3.0/10 — below 4.5 minimum
! Reward/Risk 1.3:1 at current price — below 1.5:1 minimum

Earnings

M
M
M
M
0/4 beats
Next Earnings2026-08-04 (79d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AHCO stock a buy right now?

Sell if holding. Engine safety override at $10.66: Quality below floor (1.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10. Specifically: Below-average business quality; Negative price momentum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $10.24. Score 5.1/10, moderate confidence.

What is the AHCO stock price target?

Take-profit target: $12.18 (+14.3% upside). Prior stop was $10.24. Stop-loss: $10.24.

What are the risks of investing in AHCO?

Quality below floor (1.9 < 4.0).

Is AHCO overvalued or undervalued?

AdaptHealth Corp. trades at a P/E of N/A (forward 8.8). TrendMatrix value score: 8.8/10. Verdict: Sell.

What do analysts say about AHCO?

14 analysts cover AHCO with a consensus score of 4.1/5. Average price target: $14.

What does AdaptHealth Corp. do?AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home...

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Related stocks: GMED (Globus Medical, Inc.) · PODD (Insulet Corporation) · ENOV (Enovis Corporation) · LIVN (LivaNova PLC) · ATEC (Alphatec Holdings, Inc.)